Allterum Therapeutics is a biopharmaceutical company based in Houston, Texas, that is dedicated to developing innovative treatments for IL-7R expressing cancers. With a focus on relapsed refractory hematologic malignancies and lymphomas and solid tumors with IL-7R over-expression, Allterum aims to provide much-needed options for patients who may not have effective standard treatment options available to them.
Founded in 2018 by Fannin, Allterum is part of Houston's leading early-stage life sciences development group, Fannin, which collaborates with academic institutions such as MD Anderson Cancer Center, Baylor College of Medicine, and Rice University to develop promising assets. With a strong commitment to advancing an innovative solution for critical and unmet medical needs, Allterum Therapeutics is at the forefront of oncology research and development.
Generated from the website
